Chapter 1 Introduction
1.1 Executive Summary
1.2 Market Definition
1.3 Scope of the Study
Chapter 2 Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.3 Analytic Tools and Model
2.4 Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5 Expert Validation
2.6 Study Timeline
Chapter 3 Market Analysis
3.1 Industry Value Chain Analysis
3.2 Porter's Five Analysis
3.2.1 Bargaining Power of Buyers
3.2.2 Bargaining Power of Suppliers
3.2.3 Threats of Substitutes
3.2.4 Threats of New Entrants
3.2.5 Industry Rivalry
3.3 PESTLE Analysis
3.3.1 Political
3.3.2 Economical
3.3.3 Social
3.3.4 Technological
3.3.5 Legal
3.3.6 Environmental
3.4 SWOT Analysis
3.4.1 Strengths
3.4.2 Weakness
3.4.3 Opportunities
3.4.4 Threat
3.5 Y-O-Y Analyses
Chapter 4 Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Challenges
Chapter 5 Market Segmentation Analysis
Chapter 6 Market Segmentation, By Mode of Delivery
6.1 Oral Delivery Devices
6.2 Pulmonary Drug Delivery Devices
6.3 Transdermal Drug Delivery Systems
6.4 Injectable Drug Delivery system
Chapter 7 Market Segmentation, By Mode of Action
7.1 Hydrodynamic pressure controlled system
7.2 Slow dissolving salts and complexes
7.3 Ion-exchange resin-drug complexes
7.4 PH-Independent formulations
7.5 Osmotic pressure controlled systems
7.6 Dissolution and diffusion controlled release systems
Chapter 8 Market Segmentation, By Mode of Administration
8.1 Inhalation drug delivery system by nebuliser
8.2 Inhalation drug delivery system by dry powder inhalers
8.3 Inhalation drug delivery system by metered dose inhalers
8.4 Iontophoresis
8.5 Use of microscopic projection
8.6 Application by ultrasound
8.7 Electroporation
8.8 Intraperitoneal injection
8.9 Intradermal injection
8.10 Intravenous injection
8.11 Intramuscular injection
8.12 Subcutaneous injection
Chapter 9 Market Segmentation, By Geography
9.1 Introduction
9.2 UK
9.3 Germany
9.4 France
9.5 Switzerland
9.6 Spain
9.7 Others
Chapter 10 Competitive Landscape
10.1 Mergers & Acquisitions, Joint Ventures, Collaborations, and Agreements
10.2 Market Share Analysis
10.3 Strategies Adopted By Top Companies
Chapter 11 Company Profiles (Overview, Financials, SWOT Analysis, Developments, Product Portfolio)
11.1. Activaero
11.1.1. Company Overview
11.1.2. Financial Performance
11.1.3. Product Benchmarking
11.1.4. Strategic Initiative
11.2. Medgenesis Therapeutix
11.3. Merrion Pharmaceuticals
11.4. Innocore Pharmaceuticals
11.5. Roche
11.6. Merck & Co.
11.7. 3M
11.8. Medherant
11.9. Critical Pharmaceuticals
11.10. Epistem
11.11. QuantuMDx
11.12. Apidel
11.13. Sisaf
11.14. NanoSight Ltd
11.15. Biofrontera AG
Chapter 12 Market Estimates and Forecast
12.1 Market Estimates and Forecast 2018-2024(USD Million)
12.1.1 Market Estimation and Forecast by Mode of Delivery 2018-2024 (USD Million)
12.1.2 Market Estimation and Forecast by Mode of Action 2018-2024 (USD Million)
12.1.3 Market Estimation and Forecast by Mode of Administration 2018-2024 (USD Million)
12.1.4 Market Estimates and Forecast by Geography 2018-2024 (USD Million)
Chapter 13 Market Insights
13.1 Insights of Industry Experts
13.2 Analyst Opinion (Market Understanding)
13.3 Investment Opportunities
Chapter 14 Appendix
14.1 List of Tables
14.2 List of Figures
